Interestingly, a dramatic release of IFN-γ from splenocytes in response to tumor antigens is discovered in IL-15cx treated mice but not in parental FVB mice with spontaneous rejection of neu+-MMC (Figure 3). This evidence concerns the gene ERBB2 and neoplasm.